2Fischer W,Kittner H,Regenthal R,et al.Anticonvulsant profile of flunarizine and relation to Na channel blocking effects[J].Basic Clin Pharmacol Toxicol,2004,94(2):79-88.
3Harrington MG,Fonteh AN,Cowan RP,et al.Cerebrospinal Fluid Sodium Increases in Migraine[J].Headache,2006,46(7):1128-1135.
4Martinez F,Castillo J,Pardo J,et al.Catecholamine levels in plasma and CSF in migraine[J].J Neurol Neurosurg Psychiatry,1993,56(10):1119-1121.
5Barbeliven A,Noel C,MacKenzie ET,et al.Cerebrovascular evidence for a GABA ergic modulation of the cholinergic vasodilatatory basalocortical system in the rat[J].Brain Res,1999,834(1-2):223-227.
6Welch KM,Chabi E,Bartosh K,et al.Cerebrospinal fluid gamma aminobutyric acid levels in migraine[J].Br Med J,1975,3(5982):516-517.
7Mercante JP,Peres MF,Guendler V,et al.Depression in chronic migraine:severity and clinical features[J].Arq Neuropsiquiatr,2005,63(2A):217-220.
8Vieira DS,Naffah-Mazacoratti MG,Zukerman E,et al.Cerebrospinal fluid GABA levels in chronic migraine with and without depression[J].Brain Res,2006,1090(1):197-201.
9Cutrer FM,Moskcwitz MA.Wolff Award 1996.The actions of valproate and neurosteroids in a model of trigeminal pain[J].Headache,1996,36(10):579-585.
10Martínez F,Castillo J,Rodríguez JR.Neuroexcitatory amino acid levels in plasma and cerebrospinal fluid during migraine attacks[J].Cephalalgia,1993,13(2):89-93.